| Vicky Dillon, FNP | |
|
1059 Neal St, Cookeville, TN 38501-0946 | |
| (931) 528-8593 | |
| Not Available |
| Full Name | Vicky Dillon |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1059 Neal St, Cookeville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023540457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0505X | Family Medicine - Adult Medicine | 23456 (Tennessee) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | APN23456 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Truhealth, Llc | 2163653478 | 29 |
News Archive
The American Society for Radiation Oncology has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer.
Cephalon, Inc. today announced that it has filed a definitive Consent Revocation Statement with the Securities and Exchange Commission (SEC) urging shareholders to reject Valeant Pharmaceuticals International Inc.'s proposals to remove Cephalon's entire Board of Directors and replace them with nominees hand-picked by Valeant.
David Liu, professor of chemistry and chemical biology at Harvard University is a pioneer of CRISPR-Cas9 gene-editing technology. He has now come up with two new upgrades for this gene editing tool that makes it better than before. These two tools are "cellular detective" and "sharp scissors".
Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency next week, to help improve our understanding of immunity against COVID-19 from vaccination and infection.
› Verified 3 days ago
| Entity Name | Generations Health Association, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245212380 PECOS PAC ID: 3779491907 Enrollment ID: O20041208000500 |
News Archive
The American Society for Radiation Oncology has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer.
Cephalon, Inc. today announced that it has filed a definitive Consent Revocation Statement with the Securities and Exchange Commission (SEC) urging shareholders to reject Valeant Pharmaceuticals International Inc.'s proposals to remove Cephalon's entire Board of Directors and replace them with nominees hand-picked by Valeant.
David Liu, professor of chemistry and chemical biology at Harvard University is a pioneer of CRISPR-Cas9 gene-editing technology. He has now come up with two new upgrades for this gene editing tool that makes it better than before. These two tools are "cellular detective" and "sharp scissors".
Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency next week, to help improve our understanding of immunity against COVID-19 from vaccination and infection.
› Verified 3 days ago
| Entity Name | Truhealth, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063843951 PECOS PAC ID: 2163653478 Enrollment ID: O20140331001471 |
News Archive
The American Society for Radiation Oncology has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer.
Cephalon, Inc. today announced that it has filed a definitive Consent Revocation Statement with the Securities and Exchange Commission (SEC) urging shareholders to reject Valeant Pharmaceuticals International Inc.'s proposals to remove Cephalon's entire Board of Directors and replace them with nominees hand-picked by Valeant.
David Liu, professor of chemistry and chemical biology at Harvard University is a pioneer of CRISPR-Cas9 gene-editing technology. He has now come up with two new upgrades for this gene editing tool that makes it better than before. These two tools are "cellular detective" and "sharp scissors".
Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency next week, to help improve our understanding of immunity against COVID-19 from vaccination and infection.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vicky Dillon, FNP 1059 Neal St, Cookeville, TN 38501-0946 Ph: (931) 528-8593 | Vicky Dillon, FNP 1059 Neal St, Cookeville, TN 38501-0946 Ph: (931) 528-8593 |
News Archive
The American Society for Radiation Oncology has issued an update to its recommendations for medical insurance coverage regarding the use of proton beam therapy to treat cancer.
Cephalon, Inc. today announced that it has filed a definitive Consent Revocation Statement with the Securities and Exchange Commission (SEC) urging shareholders to reject Valeant Pharmaceuticals International Inc.'s proposals to remove Cephalon's entire Board of Directors and replace them with nominees hand-picked by Valeant.
David Liu, professor of chemistry and chemical biology at Harvard University is a pioneer of CRISPR-Cas9 gene-editing technology. He has now come up with two new upgrades for this gene editing tool that makes it better than before. These two tools are "cellular detective" and "sharp scissors".
Thousands of adults a day will be given free access to antibody tests through a new national surveillance programme launched by the UK Health Security Agency next week, to help improve our understanding of immunity against COVID-19 from vaccination and infection.
› Verified 3 days ago